Introducing BRCAvantage™ Genetic Testing
Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime -- up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks.
Sonora Quest Laboratories can help provide answers with fast, economical testing; Preauthorization support; and Patient Education.
 |
 |